Azelaic acid is the better first choice if dark marks come with active acne. Topical tranexamic acid may suit pigment-only concerns or skin that stings with azelaic acid. For melasma, azelaic acid vs tranexamic acid has no clear universal winner. Direct trials are small or answer different questions. Whichever you choose, light protection and trigger control often decide whether the pigment returns.
Azelaic acid vs tranexamic acid at a glance
| What you are choosing on | Azelaic acid | Topical tranexamic acid |
|---|---|---|
| Best fit | Active acne plus the flat marks it leaves | Melasma or post-acne marks when acne control is not the main goal |
| Head-to-head result for post-acne marks | 20% cream improved marks over 12 weeks | 5% solution improved marks over 12 weeks; neither treatment beat the other |
| Melasma evidence | Older trials mainly studied 20% cream, often for up to 24 weeks | Trials usually studied 2% to 5% topical formulas, often for about 12 weeks |
| Acne benefit | Included as a conditional option in the American Academy of Dermatology's 2024 acne guideline | Not an established treatment for active acne |
| Common practical drawback | Stinging, burning, redness or dryness can limit use | Often less irritating in small trials, but the evidence base is thinner |
| Key safety distinction | This comparison concerns topical treatment | Topical and oral tranexamic acid are different decisions; tablets require medical screening |
First identify the pigment you are treating
Flat brown marks left exactly where acne healed are usually post-inflammatory hyperpigmentation, or PIH. New breakouts keep creating new marks. That makes azelaic acid a practical first choice because it can address acne and pigment in one step.
Melasma usually forms broader, often symmetrical patches on the cheeks, forehead or upper lip. It tends to return, so maintenance matters as much as fading. This guide to freckles, sun spots and melasma explains the visible patterns. A photo or checklist still cannot confirm a diagnosis.
If you are not sure a patch is melasma or a post-acne mark, get it assessed before applying a pigment treatment.
What did direct comparisons find?
Yes, the two ingredients have been compared directly. The cleanest topical comparison concerns post-acne marks, not melasma.
Sobhan and colleagues ran a single-blind randomised trial in 82 adults with acne-related PIH. Participants used either 20% azelaic acid cream or 5% tranexamic acid solution for 12 weeks. Sixty completed the trial. Both groups improved, and the change over time did not differ between treatments.
Tolerability separated them early. At week four, 36.6% of azelaic acid completers reported redness or burning, versus 3.3% with tranexamic acid. Eleven people assigned azelaic acid had already withdrawn because of side effects. That dropout makes the final comparison less secure, but it reinforces the tolerance issue.
Malik and colleagues also compared topical 3% tranexamic acid with 20% azelaic acid in 100 people with melasma. Both groups also took oral tranexamic acid and used sunscreen. Scores did not differ at months two or four. At month six, the topical tranexamic acid group had the lower average melasma score.
That study is not a clean test of two topical products. Oral tranexamic acid in both groups could have driven much of the change. It also cannot tell you whether a consumer serum matches the study formula.
Separate studies do not settle the contest
Chang and colleagues pooled 45 melasma studies with 2,359 participants. Azelaic acid and tranexamic acid produced similar standardized changes from baseline. Yet only three azelaic acid studies and 11 tranexamic acid studies entered those estimates. Study methods also varied sharply.
This is useful evidence that both can work. It is not proof that they work equally well, because most participants were not randomised between these two ingredients.
The older azelaic acid evidence used stronger formulas than many shop-bought products. Baliña and Graupe studied 20% azelaic acid against 4% hydroquinone in 329 women for 24 weeks. Both groups used broad-spectrum sunscreen. Azelaic acid produced good or excellent ratings in 65%, with no clear difference from hydroquinone.
For topical tranexamic acid, Atefi and colleagues randomised 60 women to 5% tranexamic acid or 2% hydroquinone for 12 weeks. Both groups improved, with no clear difference in average melasma scores. One clinic and 60 participants leave plenty of uncertainty.
Concentration matters. A 10% azelaic acid cosmetic has not inherited the results of a 20% clinical cream. The same warning applies to tranexamic acid blends with several brightening ingredients. See the azelaic acid strength comparison or the fuller tranexamic acid evidence guide before treating percentages as interchangeable.
How long should you give either option?
Think in months, not days. The direct PIH trial recorded progress at weeks four, eight and 12. The major azelaic acid melasma trial lasted 24 weeks. A fair first review is around eight to 12 weeks, unless irritation forces an earlier change.
Take one baseline photo in soft, even light. Repeat it with the same camera, distance, angle and exposure. Daily mirror checks are too noisy. This is an editorial tracking method, not a validated test, and it cannot prove why pigment changed.
The expected timeline also depends on pigment depth and whether new inflammation continues. The guide to how long hyperpigmentation takes to fade separates those factors.
How to keep the pigment from coming back
Stop the source first. For acne-related PIH, that means controlling breakouts and avoiding picking. For melasma, it means sustained protection from ultraviolet and visible light while limiting irritation.
Boukari and colleagues tested two sunscreens with the same ultraviolet filters during spring and summer. Only the tinted formula contained iron oxides for short-wavelength visible light. Among 39 analysed patients, median melasma scores rose by 0.45 points with the tinted formula. They rose by 2.43 points with the untinted formula over six months.
It was a small, industry-supported study, so the exact numbers should not be treated as a guarantee. The practical lesson is narrower. If melasma keeps returning, choose broad-spectrum protection you will wear daily. A tinted formula with iron oxides can add visible-light coverage.
Don't stack several new acids, scrubs and retinoids at once. Change one variable, follow the product label and use a plain moisturiser if needed. Persistent burning is a reason to reassess, not proof that pigment is fading.
How to decide, and when a dermatologist should decide
- Choose azelaic acid first when active acne and its leftover marks are linked problems.
- Choose topical tranexamic acid when pigment is the main target and azelaic acid repeatedly irritates your skin.
- For melasma, base the choice on tolerance, access and prior response. Current evidence does not name one universal winner.
Oral tranexamic acid is not a stronger version of a serum. In the United States, its tablet label covers heavy menstrual bleeding, not melasma. The label lists combined hormonal contraception and current, past or intrinsic clot risk as contraindications. A prescriber must assess those risks before considering off-label melasma treatment.
See a dermatologist when the diagnosis is uncertain or a sensible topical trial produces no movement. Get professional advice during pregnancy or breastfeeding, before combining prescription treatments, and before any oral or injected tranexamic acid.
Oscar Nascimento
Editorial writer, GlowUp Face
Oscar writes about evidence-based skin care, healthcare, looksmaxxing, and the social and economic research surrounding appearance.
Full profile and all articles →
